Navigation Links
Antibody Finding Might Help in Search for HIV Vaccine
Date:7/14/2011

By Randy Dotinga
HealthDay Reporter

THURSDAY, July 14 (HealthDay News) -- Researchers report that they've gained insight into the workings of the immune system's response to HIV, the AIDS virus, in certain people, potentially providing a boost as scientists work toward a vaccine.

The findings won't have an immediate big impact on either vaccine research or HIV treatment. However, they do reveal how soldiers of the immune system known as antibodies use special powers to combat the virus in some patients, said study co-author Dr. Michel C. Nussenzweig, a professor of immunology at The Rockefeller University in New York City.

Ultimately, he said, scientists could develop a vaccine that teaches people's bodies how to make the antibodies. "You'd try to make them do it themselves," he said, instead of pumping antibodies into the body.

Since the late 1990s, AIDS has largely become a treatable, chronic disease. But it can still be deadly, and many scientists think they're years away from developing a vaccine to prevent people from becoming infected in the first place.

In the new study, published online July 14 in Science, researchers focused on antibodies that are produced only in certain patients with HIV. They work by preventing the virus from picking the locks in cells that are supposed to keep germs out.

The problem is that the antibodies don't help cells that have already been infected, Nussenzweig said. And the antibodies only appear about two to three years after someone has been infected with the virus, he said. It's not clear how much the antibodies help those people.

Nussenzweig and colleagues were able to clone the antibodies from four patients. "It's possible that if you were to have enough of these things, there might even be a therapy" for people with the virus, he said. In other words, the antibodies could become part of a drug.

However, the antibodies don't live long, meaning patients would have to undergo repeated and regular treatments if they wanted the protection they may be able to provide, he said. For now, he said, the research seems more likely to help the development of a vaccine.

U.S. National Institutes of Health vaccine researcher Dr. John Mascola said the findings extend "prior work to show that the human immune system can make antibodies that target vulnerable regions of HIV."

Dr. Jonathan D. Fuchs, director of Vaccine Studies at the San Francisco Department of Public Health, said the findings represent an "important advance" because they help define the types of antibodies that vaccines need to elicit in the body.

More information

For more about HIV/AIDS, visit the U.S. National Library of Medicine.

SOURCES: Michel C. Nussenzweig, Ph.D., M.D., professor, immunology, Rockefeller University and Howard Hughes Medical Institute, New York City; John R. Mascola, M.D., Vaccine Research Center, U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.; Jonathan D. Fuchs, M.D., M.P.H., director, Vaccine Studies, San Francisco Department of Public Health; July 14, 2011, Science, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Disorderly enzyme is key for antibody diversity
2. Combination antibody therapy shows promise in metastatic melanoma
3. Antibody-guided drug works against acute lymphoblastic leukemia
4. Antibody production gets confused during long-term spaceflight
5. Tiny antibody fragments raised in camels find drug targets in human breast cancer cells
6. Tufts receives patent for antibody treatment against hemolytic uremic syndrome
7. HJF signs distribution agreement for antibody to evaluate prostate cancer
8. Antibody Linked to Allergies on the Rise
9. Antibody therapy lengthens survival of metastatic melanoma patients in large clinical trial
10. Fox Chase clinical trial tests first of its kind antibody
11. NIH supports new research strategy for finding a cure for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antibody Finding Might Help in Search for HIV Vaccine
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology: